Form 4: QuidelOrtho Corp: SVP Werner Kroll Reports Stock Transactions

SVP of Research & Development at QuidelOrtho Corp, Werner Kroll, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• Werner Kroll, SVP of Research & Development at QuidelOrtho Corp, filed a Form 4 on July 30, 2024.
• The filing reports transactions that occurred on July 28, 2024.
• Kroll acquired 1,170 shares of common stock upon the vesting of restricted stock units.
• Simultaneously, 594 shares were disposed of to cover tax withholding obligations at a price of $38.91 per share.
• Following these transactions, Kroll directly owns 36,357 shares of QuidelOrtho Corp.
• The restricted stock units vested in three tranches: 1,170 shares on July 28, 2022, 1,170 shares on July 28, 2023, and 1,170 shares on July 28, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to stock vesting and tax obligations. There's no indication of unusual activity or concern.

Positives

• The vesting of restricted stock units suggests that Kroll has met certain performance or time-based milestones within the company.
• Continued stock ownership aligns Kroll's interests with those of the shareholders.

Negatives

• The sale of shares to cover tax obligations, while common, slightly reduces Kroll's overall stake in the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Comparing Kroll's transactions to those of executives at similar diagnostic companies like Abbott Laboratories or Roche could provide context on the scale and frequency of insider trading.
• Analyzing the vesting schedules and tax withholding practices against industry norms can reveal whether QuidelOrtho's compensation structure is competitive.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect standard compensation practices and insider ownership adjustments.

Key Dates